
Currently, high-production rates and continuous production processes favor existing tableting technologies. However, if tablet development becomes rate-limiting in the future, alternative technologies may prove attractive.
Brian A.C. Carlin, PhD, is the global manager of pharmaceutical R&D at FMC BioPolymer, Route 1 at Plainsboro Road, Princeton, NJ 08543, tel. 609.951.3741, fax 609.951.3680, [email protected]

Currently, high-production rates and continuous production processes favor existing tableting technologies. However, if tablet development becomes rate-limiting in the future, alternative technologies may prove attractive.